Table 2 The clinical characteristics of patients.

From: The effect of genetic polymorphisms on treatment duration following premolar extraction

Clinical variables

All patient (n = 117)

Extreme short group (n = 18)

Extreme long group (n = 18)

P value* Short vs long)

Age (years), median (range)

19.8 (12–46.9)

18.4 (12–34.3)

19.5 (12–26.7)

0.558

Gender, n (%)

Female

93 (79.5)

15 (83.3)

13 (72.2)

0.423

Male

24 (20.5)

3 (16.7)

5 (27.8)

Angle classification, n (%)

Class I

44 (37.6)

7 (38.9)

7 (38.9)

0.073

Class II

57 (48.7)

10 (55.6)

5 (27.8)

Class III

16 (13.7)

1 (5.5)

6 (33.3)

Horizontal anterior retraction(mm), mean ± SD

4.45 (2.79)

4.07 (2.82)

3.99 (2.77)

0.934

Crowding (mm), mean ± SD

3.72 (3.61)

5.14 (3.45)

4.16 (3.88)

0.424

Displacement (mm),

3.97 (3.33)

5.14 (3.45)

4.84 (2.91)

0.780

Overjet (mm)

3.26 (2.29)

3.36 (2.01)

2.35 (2.11)

0.150

Overbite (mm)

1.57 (2.07)

0.53 (2.72)

1.36 (1.79)

0.285

ANB (T1)

4.01 (2.43)

4.57 (2.05)

3.43 (3.29)

0.220

ANB (T2)

3.66 (2.49)

4.25 (1.72)

3.08 (3.49)

0.212

FMA (T1)

29.90 (5.52)

31.17 (6.06)

28.66 (6.70)

0.246

FMA (T2)

30.24 (8.73)

30.21 (5.60)

28.61 (6.58)

0.436

U1 to SN (T1)

107.16 (7.07)

106.08 (8.05)

106.94 (9.52)

0.771

U1 to SN (T2)

101.00 (6.13)

100.41 (6.13)

102.13 (6.98)

0.437

PAR (unweighted)

5.22 (2.69)

6.00 (2.47)

6.17 (3.31)

0.865

PAR (weighted)

15.75 (9.97)

17.50 (9.95)

18.67 (12.42)

0.758

Treatment duration

26.59 (7.94)

15.67 (4.78)

39.06 (5.06)

< 0.001

  1. Bold values denote statistical significance at the P < 0.05 level.
  2. *Chi-square test or t test were used where appropriate.